HEXA and Tay-Sachs disease: An ideal TSD mouse model was recently developed through a combined deficiency of HexA and Neu3, which mimics the neuropathological and clinical abnormalities of classical early-onset TSD patients and may provide a valuable tool for treatments development for this condition [12].